Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2012

01-06-2012 | Case Report

Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT

Authors: Nurhan Ergül, Şebnem İzmir Güner, Sait Sağer, Gülben Erdem Huq, Hediye Çiftçi, T. Fikret Çermik

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

The involvement of breast tissue with Hodgkin’s lymphoma (HL) has been reported in very few cases up to date. We report a 33-year-old woman who had been treated and followed up with nodular sclerosing HL for 7 years, and admitted with recurrent disease. The fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) images revealed disseminated disease with the involvement of bilateral breast tissues showing FDG uptake. In this case, the breast involvement of HL was confirmed by histopathological results.
Literature
1.
Zucca E. Extranodal lymphoma: a reappraisal. Ann Oncol. 2008;19:77–80.
2.
Guermazi A, Brice P, de Kerviler EE, Fermé C, Hennequin C, Meignin V, Frija J. Extranodal Hodgkin disease: spectrum of disease. Radiographics. 2001;21:161–79.PubMed
3.
Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics. 2010;30:269–91.PubMedCrossRef
4.
Yang WT, Lane DL, Le-Petross HT, Abruzzo LV, Macapinlac HA. Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology. 2007;245:692–702.PubMedCrossRef
5.
Cao YB, Wang SS, Huang HQ, Xu GC, He YJ, Guan ZZ, Lin TY. Primary breast lymphoma–a report of 27 cases with literature review. Ai Zheng. 2007;26:84–9.PubMed
6.
Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32:1299–309.PubMedCrossRef
7.
Garg NK, Bagul NB, Rubin G, Shah EF. Primary lymphoma of the breast involving both axilla with bilateral breast carcinoma. World J Surg Oncol. 2008;6:52.PubMedCrossRef
8.
Bakheet SM, Bakheet R, Ezzat A, Tulbah A, Durakovic A, Hussain S. F-18 FDG positron emission tomography in primary breast non-Hodgkin’s lymphoma. Clin Nucl Med. 2001;26:299–301.PubMedCrossRef
9.
Mocikova H, Obrtlikova P, Vackova B, Trneny M. Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study. Ann Oncol. 2009;21:1222–7.PubMedCrossRef
10.
Park J, Rizzo M, Jackson S, Bates SR, Green V, Oprea-Ilies G. Reed–Sternberg cells in breast FNA of a patient with left breast mass. Diagn Cytopathol. 2010;38:663–8.PubMedCrossRef
11.
Hoimes CJ, Selbst MK, Shafi NQ, Rose MG, Rosado MF. Hodgkin’s lymphoma of the breast. J Clin Oncol. 2010;28:e11–3.PubMedCrossRef
12.
Aksu G, Inan N, Corapcioglu F, Tugay M, Anik YA. Breast involvement in nodular lymphocyte predominant type Hodgkin lymphoma in childhood. Pediatr Hematol Oncol. 2008;25:159–61.PubMedCrossRef
13.
Kumar R, Xiu Y, Dhurairaj T, Yu JQ, Alavi A, Zhuang H. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast. Clin Nucl Med. 2005;30:246–8.PubMedCrossRef
Metadata
Title
Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT
Authors
Nurhan Ergül
Şebnem İzmir Güner
Sait Sağer
Gülben Erdem Huq
Hediye Çiftçi
T. Fikret Çermik
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9877-0

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue

Original Paper

PTEN’s regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia

Original Paper

Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma

Original Paper

HLA class-II allele frequencies in Turkish breast cancer patients

Original Paper

Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy

Original Paper

The TP53 gene polymorphisms and survival of sporadic breast cancer patients

Original Paper

MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits